Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPR3 | P17342 | 2/20 | 0.60 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.60 |
| ▸ | TAS1R3 | Q7RTX0 | 8/20 | 0.46 |
| ▸ | TAS1R1 | Q7RTX1 | 8/20 | 0.46 |
| ▸ | ELANE | P08246 | 6/20 | 0.46 |
| ▸ | NOS3 | P29474 | 3/20 | 0.43 |
| ▸ | NOS1 | P29475 | 3/20 | 0.43 |
| ▸ | NOS2 | P35228 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6508225 | 1.00 | NPR3 (0.60) | NPR3CYP2C9CYP2C19TAS1R3TAS1R1 | |
| SCHEMBL17424044 | 0.85 | NPR3 (0.78) | NPR3CYP2C9CYP2C19TAS1R3TAS1R1 | |
| SCHEMBL6512165 | 0.83 | NPR3 (0.47) | NPR3CYP2C9CYP2C19TAS1R3TAS1R1 | |
| SCHEMBL6512169 | 0.83 | NPR3 (0.47) | NPR3CYP2C9CYP2C19TAS1R3TAS1R1 | |
| SCHEMBL6508740 | 0.82 | NPR3 (0.53) | NPR3CYP2C9CYP2C19TAS1R3TAS1R1 | |
| SCHEMBL6508736 | 0.82 | NPR3 (0.53) | NPR3CYP2C9CYP2C19TAS1R3TAS1R1 | |
| SCHEMBL6511358 | 0.81 | NPR3 (0.45) | NPR3CYP2C9CYP2C19TAS1R3TAS1R1 | |
| SCHEMBL6511364 | 0.81 | NPR3 (0.45) | NPR3CYP2C9CYP2C19TAS1R3TAS1R1 | |
| SCHEMBL6510872 | 0.79 | NPR3 (0.44) | NPR3CYP2C9CYP2C19ELANE | |
| SCHEMBL6510875 | 0.79 | NPR3 (0.44) | NPR3CYP2C9CYP2C19ELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005003103-A2 | 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES | ASTRAZENECA AB (SE) | 2005-01-13 | — | — | WO | disclosed |